Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 02, 2023 06:03 ET | Source: Research and Markets

Global Filgrastim Biosimilars Market Research Report 2023: Focus on Zarxio, Nivestym, and Releuko

Dublin, May 02, 2023 (GLOBE NEWSWIRE) -- The "Filgrastim Biosimilars Global Market Report 2023" report has been added to ResearchAndMarkets.com's offering.The global filgrastim biosimilars market...
March 06, 2023 08:00 ET | Source: Coherus BioSciences, Inc.

FDA Approves UDENYCA® Autoinjector

- UDENYCA® is the only pegfilgrastim therapy delivered in a convenient, easy-to-administer prefilled autoinjector to offer in-clinic and at-home administration options for cancer patients undergoing...
March 22, 2022 05:23 ET | Source: Research and Markets

Global Pegfilgrastim Biosimilars Market Report (2022 to 2031) - Featuring Mylan, Biocon and Mundipharma Among Others

Dublin, March 22, 2022 (GLOBE NEWSWIRE) -- The "Pegfilgrastim Biosimilars Global Market Report 2022: By Application, By Distribution" report has been added to ResearchAndMarkets.com's offering. This...
March 16, 2022 06:38 ET | Source: Research and Markets

Global $4,037 Million Pegfilgrastim Biosimilars Markets, Analysis & Forecasts, 2015-2020, 2025F, 2030F

Dublin, March 16, 2022 (GLOBE NEWSWIRE) -- The "Pegfilgrastim Biosimilars Global Market Opportunities And Strategies To 2030, By Application, Distribution Channel" report has been added to...
January 21, 2022 04:29 ET | Source: Research and Markets

Worldwide Filgrastim Industry to 2027 - An Increase in the Aging Population is Driving Growth

Dublin, Jan. 21, 2022 (GLOBE NEWSWIRE) -- The "Global Filgrastim Market By Drug Type, By Indication, By Distribution Channel, By Regional Outlook, Industry Analysis Report and Forecast, 2021 - 2027"...
October 25, 2021 04:18 ET | Source: Research and Markets

Global $880 Million Pegfilgrastim Biosimilars Markets, 2015-2020, 2020-2025F, 2030F

Dublin, Oct. 25, 2021 (GLOBE NEWSWIRE) -- The "Pegfilgrastim Biosimilars Global Market Report 2021: COVID-19 Growth and Change to 2030" report has been added to ResearchAndMarkets.com's offering....
October 20, 2021 04:13 ET | Source: Research and Markets

Global $1.04 Bn Filgrastim Biosimilars Markets, 2015-2020, 2020-2025F, 2030F

Dublin, Oct. 20, 2021 (GLOBE NEWSWIRE) -- The "Filgrastim Biosimilars Global Market Report 2021: COVID-19 Growth and Change to 2030" report has been added to ResearchAndMarkets.com's offering. The...
February 03, 2021 03:58 ET | Source: Research and Markets

Global Pegfilgrastim Biosimilars Market Report 2020: COVID-19 Growth and Change - Market to Decline by 15.2% and will Recover by 2023 - Forecast 2030

Dublin, Feb. 03, 2021 (GLOBE NEWSWIRE) -- The "Pegfilgrastim Biosimilars Global Market Report 2020-30: COVID-19 Growth and Change" report has been added to ResearchAndMarkets.com's offering. Major...
January 14, 2021 10:48 ET | Source: Research and Markets

Global Filgrastim Biosimilars Market Opportunities and Strategies Report 2020-2030 Featuring Teva Pharma, Novartis International, Biocon, Intas Biopharmaceuticals, Dr. Reddy's Laboratories

Dublin, Jan. 14, 2021 (GLOBE NEWSWIRE) -- The "Filgrastim Biosimilars Global Market Opportunities and Strategies to 2030: COVID-19 Implications and Growth" report has been added to...
January 12, 2021 10:23 ET | Source: Research and Markets

Global Pegfilgrastim Biosimilars Market Report 2020-2030: COVID-19 Opportunities and Strategies, Impacts and Recovery

Dublin, Jan. 12, 2021 (GLOBE NEWSWIRE) -- The "Pegfilgrastim Biosimilars Global Market Opportunities and Strategies to 2030: COVID-19 Impact and Recovery" report has been added to...